remoxipride has been researched along with Psychoses, Drug in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eriksson, L | 1 |
| George, A; Gray, P; Grimes, JD; Mendis, T; Mohr, E; Rusk, IN | 1 |
| Angus, C; Lang, AE; Sandor, P; Singal, S | 1 |
| Andersson, U; Häggström, JE; Nilsson, MI; Widerlöv, E | 1 |
2 trial(s) available for remoxipride and Psychoses, Drug
| Article | Year |
|---|---|
Remoxipride in the treatment of levodopa-induced psychosis.
Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Dopamine Antagonists; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease; Psychoses, Substance-Induced; Remoxipride | 1996 |
Remoxipride, a selective dopamine D2 receptor antagonist, in tardive dyskinesia.
Topics: Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzamides; Blood Chemical Analysis; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Electrocardiography; Female; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Psychoses, Substance-Induced; Remoxipride | 1988 |
2 other study(ies) available for remoxipride and Psychoses, Drug
| Article | Year |
|---|---|
Remoxipride in the treatment of psychoses.
Topics: Adult; Basal Ganglia Diseases; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Psychotic Disorders; Receptors, Dopamine D2; Remoxipride; Retrospective Studies; Schizophrenia | 1994 |
Symptomatic relief from treatment-induced psychosis in Parkinson's disease: an open-label pilot study with remoxipride.
Topics: Aged; Aged, 80 and over; Carbidopa; Drug Therapy, Combination; Female; Humans; Levodopa; Limbic System; Long-Term Care; Male; Mesencephalon; Middle Aged; Parkinson Disease; Pilot Projects; Psychoses, Substance-Induced; Receptors, Dopamine D2; Remoxipride | 1994 |